Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
TWST Twist Bioscience Corporation daily Stock Chart
TWST [NASD]
Twist Bioscience Corporation
Healthcare | Medical Laboratories & Research | USA
financial highlights | statements
Index- P/E- EPS (ttm)-3.22 Insider Own21.10% Shs Outstand26.68M Perf Week14.90%
Market Cap876.70M Forward P/E- EPS next Y-2.66 Insider Trans- Shs Float22.11M Perf Month49.16%
Income-76.90M PEG- EPS next Q-0.97 Inst Own35.10% Short Float1.71% Perf Quarter50.53%
Sales32.60M P/S26.89 EPS this Y-20.10% Inst Trans0.04% Short Ratio5.28 Perf Half Y-
Book/sh7.22 P/B4.55 EPS next Y34.00% ROA- Target Price28.50 Perf Year-
Cash/sh4.88 P/C6.73 EPS next 5Y- ROE- 52W Range12.38 - 34.46 Perf YTD42.31%
Dividend- P/FCF- EPS past 5Y- ROI-71.20% 52W High-4.64% Beta-
Dividend %- Quick Ratio7.40 Sales past 5Y- Gross Margin-12.10% 52W Low165.43% ATR1.89
Employees289 Current Ratio7.70 Sales Q/Q167.40% Oper. Margin- RSI (14)83.81 Volatility7.39% 7.61%
OptionableNo Debt/Eq0.07 EPS Q/Q-85.40% Profit Margin- Rel Volume2.52 Prev Close30.34
ShortableYes LT Debt/Eq0.05 EarningsApr 30 AMC Payout- Avg Volume71.46K Price32.86
Recom2.00 SMA2026.46% SMA5040.14% SMA20042.65% Volume174,332 Change8.31%
Nov-26-18Initiated JP Morgan Neutral $27
Apr-18-19 08:00AM  Twist Bioscience to Report Fiscal 2019 Second Quarter Financial Results on Tuesday, April 30, 2019 Business Wire
Apr-15-19 08:00AM  Twist Bioscience and iGEM Partner to Provide Synthetic DNA for iGEM Competition and Registry Business Wire
Apr-11-19 08:00AM  Twist Bioscience Announces Antibody Optimization Agreement with Pandion Therapeutics Business Wire
Apr-10-19 08:43AM  Twist Bioscience (TWST) Looks Good: Stock Adds 6.5% in Session Zacks
Apr-09-19 08:01AM  Twist Bioscience Customized Libraries for Biologics Discovery Highlighted at PEGS Boston 2019 Business Wire +6.49%
08:00AM  Twist Bioscience Adopts Battelles ThreatSEQ DNA Screening Web Service for Advanced Biosecurity Business Wire
Apr-04-19 08:00AM  Twist Bioscience and LakePharma Form Strategic Collaboration to Provide Antibody Discovery and Development Services Business Wire -5.21%
Apr-01-19 08:00AM  Twist Bioscience Announces Presentations and User Group Meeting at PEGS Boston 2019 Business Wire
Mar-05-19 08:00AM  Twist Bioscience to Present at Cowen 39th Annual Healthcare Conference Business Wire
Feb-28-19 01:45PM  Twist Bioscience Showcases Next-Generation Sequencing Solutions at the 2019 Advances in Genome Biology and Technology Meeting Business Wire
Feb-07-19 06:03PM  Twist Bioscience: Fiscal 1Q Earnings Snapshot Associated Press
04:05PM  Twist Bioscience Reports First Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress Business Wire
04:04PM  Twist Bioscience Announces Appointment of Martin Kunz as Senior Vice President, Operations Business Wire
Jan-30-19 08:00AM  Twist Bioscience Chief Technology Officer Presented at Praesens Foundation Future Health Threats Initiative 2019 Business Wire
Jan-29-19 09:38AM  What's next for this slow-moving Peninsula biotech IPO? American City Business Journals
Jan-28-19 08:00AM  Twist Bioscience to Report Fiscal 2019 First Quarter Financial Results on Thursday, February 7, 2019 Business Wire
Jan-23-19 08:00AM  Twist Bioscience Receives ISO 13485:2016 and 9001:2015 Certifications of its Quality Management Systems for NGS Target Enrichment Panels Business Wire
Jan-11-19 02:05PM  8 of the 10 biggest Q4 startup exits in Bay Area came from IPOs in October American City Business Journals -5.12%
Jan-09-19 09:09AM  Government shutdown may mean an IPO-less January American City Business Journals
Jan-07-19 08:00AM  Twist Bioscience Enhances Genes Product Offering with Longer Genes and Offers Access to Its Application Programming Interface Business Wire
Jan-02-19 08:00AM  Twist Bioscience to Present at the 37th Annual J.P. Morgan Healthcare Conference Business Wire +5.93%
Dec-20-18 09:48PM  Twist Bioscience Corp (TWST) Files 10-K for the Fiscal Year Ended on September 30, 2018 GuruFocus.com -11.21%
Dec-19-18 04:05PM  Twist Bioscience Reports Fiscal 2018 Fourth Quarter and Full Year Financial Results and Highlights Commercial and Operational Progress Business Wire
Dec-10-18 10:58AM  Here's Why Twist Bioscience Stock Soared 89% in November Motley Fool -15.94%
Dec-05-18 08:00AM  Twist Bioscience to Report Fiscal 2018 Fourth Quarter and Full Year Financial Results on Wednesday, December 19, 2018 Business Wire
Nov-27-18 08:00AM  Twist Bioscience to Present at the Evercore ISI HealthCONx Conference Business Wire -9.29%
Nov-26-18 02:03PM  Here's how much better insiders have profited from this year's IPO boom American City Business Journals
08:00AM  Twist Bioscience Appoints Experienced Technology Executive Jan Johannessen to Board of Directors Business Wire
Oct-31-18 02:45PM  Twist Bioscience Corporation Announces Pricing of Initial Public Offering Business Wire
Oct-28-18 10:53AM  IPO Outlook For The Week: Banks And Biotechs Benzinga
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. Twist Bioscience Corporation has a collaboration agreement with Pandion Therapeutics, Inc. to apply its antibody optimization platform for a targeting arm of a bispecific antibody. The company was founded in 2013 and is headquartered in San Francisco, California.
open in yahoo | open in reuters | open in google